CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Organogenesis Holdings Inc. - ORGO CFD

    4.24
    3.67%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 0.05
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    Organogenesis Holdings Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

    关键数据
    前收盘价* 4.09
    开仓* 4.21
    1 年变化* -21.16%
    日范围* 4.13 - 4.24
    52 周范围 1.80-6.52
    平均交易量（10 天） 1.28M
    平均交易量（3 个月) 31.03M
    市值 538.17M
    市盈率 40.32
    流通股 131.26M
    收入 461.42M
    EPS 0.10
    股息（收益率 %） N/A
    贝塔 1.33
    下一个财报发布日期 Aug 7, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low
    Jun 7, 2023 4.24 0.15 3.67% 4.09 4.26 4.09
    Jun 6, 2023 4.09 0.11 2.76% 3.98 4.20 3.98
    Jun 5, 2023 4.01 0.06 1.52% 3.95 4.12 3.75
    Jun 2, 2023 3.94 0.33 9.14% 3.61 3.97 3.58
    Jun 1, 2023 3.67 0.13 3.67% 3.54 3.71 3.50
    May 31, 2023 3.62 -0.16 -4.23% 3.78 3.81 3.56
    May 30, 2023 3.78 0.03 0.80% 3.75 3.85 3.52
    May 26, 2023 3.75 0.01 0.27% 3.74 3.85 3.62
    May 25, 2023 3.78 -0.15 -3.82% 3.93 4.00 3.73
    May 24, 2023 3.97 0.07 1.79% 3.90 4.14 3.77
    May 23, 2023 3.41 0.04 1.19% 3.37 3.57 3.31
    May 22, 2023 3.39 0.23 7.28% 3.16 3.52 3.16
    May 19, 2023 3.18 0.09 2.91% 3.09 3.27 3.08
    May 18, 2023 3.07 -0.04 -1.29% 3.11 3.24 2.97
    May 17, 2023 3.14 0.13 4.32% 3.01 3.22 2.94
    May 16, 2023 3.00 -0.10 -3.23% 3.10 3.10 2.86
    May 15, 2023 3.14 0.09 2.95% 3.05 3.23 2.99
    May 12, 2023 3.08 0.24 8.45% 2.84 3.17 2.84
    May 11, 2023 2.84 0.53 22.94% 2.31 2.95 2.27
    May 10, 2023 2.07 -0.07 -3.27% 2.14 2.28 2.06

    Organogenesis Holdings Inc. Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Tuesday, June 13, 2023

    时间（协调世界时） (UTC)

    15:00

    国家/地区

    US

    事件

    Organogenesis Holdings Inc Annual Shareholders Meeting
    Organogenesis Holdings Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Friday, June 23, 2023

    时间（协调世界时） (UTC)

    15:00

    国家/地区

    US

    事件

    Organogenesis Holdings Inc Annual Shareholders Meeting
    Organogenesis Holdings Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Monday, August 7, 2023

    时间（协调世界时） (UTC)

    20:00

    国家/地区

    US

    事件

    Q2 2023 Organogenesis Holdings Inc Earnings Release
    Q2 2023 Organogenesis Holdings Inc Earnings Release

    Forecast

    -

    Previous

    -
    Tuesday, November 7, 2023

    时间（协调世界时） (UTC)

    10:59

    国家/地区

    US

    事件

    Q3 2023 Organogenesis Holdings Inc Earnings Release
    Q3 2023 Organogenesis Holdings Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 450.893 468.059 338.298 260.981 193.449
    收入 450.893 468.059 338.298 260.981 193.449
    总营业费用 428.589 397.024 309.352 292.697 247.1
    销售/一般/行政费用，总计 283.808 250.2 204.193 200.088 161.961
    营业收入 22.304 71.035 28.946 -31.716 -53.651
    税前净收入 20.282 63.786 17.764 -38.559 -64.747
    税后净收入 15.532 94.902 17.234 -38.709 -64.831
    未计算非常项目前的净收益 15.532 94.902 17.234 -38.709 -64.831
    净收入 15.532 94.902 17.234 -38.709 -64.831
    普通股股东可获收益 (不含非经常性项目) 15.532 94.902 17.234 -39.277 -64.831
    普通股股东可获收益 (含非經常性項目) 15.532 94.902 17.234 -39.277 -64.831
    摊薄净收入 15.532 94.902 17.234 -39.277 -64.831
    摊薄后加权平均股 132.383 133.663 111.361 92.8404 69.3185
    扣除特别项目的每股摊薄盈利 0.11733 0.71001 0.15476 -0.42306 -0.93526
    每股正常摊薄盈利 0.13045 0.74204 0.14058 -0.41002 -0.91562
    利息收入（费用），非经营净值 -2.009 -7.236 -11.279 -6.856 -11.258
    Total Adjustments to Net Income 0 0 -0.568
    收入成本，共计 105.019 114.199 87.319 75.948 68.808
    毛利 345.874 353.86 250.979 185.033 124.641
    研究与开发 39.762 30.742 20.086 14.799 10.742
    利息费用（收入) - 净运营 3.494
    异常费用（收入） 0 1.883 -2.246 1.862 2.095
    其他，净值 -0.013 -0.013 0.097 0.013 0.162
    少数股东权益 0
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 107.642 115.516 116.859 121.401 97.117
    收入 107.642 115.516 116.859 121.401 97.117
    收入成本，共计 26.607 27.11 26.177 26.652 25.08
    毛利 81.035 88.406 90.682 94.749 72.037
    总营业费用 111.643 106.798 115.08 109.466 97.245
    销售/一般/行政费用，总计 73.834 68.293 79.328 72.609 63.578
    研究与开发 11.202 11.395 9.575 10.205 8.587
    异常费用（收入） 0 0
    营业收入 -4.001 8.718 1.779 11.935 -0.128
    利息收入（费用），非经营净值 -0.649 0.03 -0.572 -0.73 -0.737
    其他，净值 0.023 0.006 0.005 -0.021 -0.003
    税前净收入 -4.627 8.754 1.212 11.184 -0.868
    税后净收入 -2.969 7.486 0.215 8.744 -0.913
    未计算非常项目前的净收益 -2.969 7.486 0.215 8.744 -0.913
    净收入 -2.969 7.486 0.215 8.744 -0.913
    普通股股东可获收益 (不含非经常性项目) -2.969 7.486 0.215 8.744 -0.913
    普通股股东可获收益 (含非經常性項目) -2.969 7.486 0.215 8.744 -0.913
    摊薄净收入 -2.969 7.486 0.215 8.744 -0.913
    摊薄后加权平均股 131.084 131.867 132.233 132.601 128.789
    扣除特别项目的每股摊薄盈利 -0.02265 0.05677 0.00163 0.06594 -0.00709
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 -0.01319 0.06163 0.00463 0.06973 -0.00576
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 222.609 226.979 174.344 125.6 71.131
    现金和短期投资 102.478 113.929 84.394 60.174 21.291
    Cash 102.478 113.929 84.394 60.174 21.291
    Prepaid Expenses 5.086 4.969 4.935 2.953 2.328
    Total Assets 449.359 443.259 294.494 220.687 163.678
    Other Long Term Assets, Total 31.534 33.531 0.688 1.011 0.817
    Total Current Liabilities 75.023 82.005 68.217 59.894 66.388
    Accrued Expenses 38.155 48.374 23.973 23.45
    Notes Payable/Short Term Debt 0 0 0 0 2.545
    Other Current Liabilities, Total 0 1.436 0.578 5 37.177
    Total Liabilities 183.69 201.224 148.41 165.104 116.637
    Total Long Term Debt 66.231 70.769 64.486 97.549 49.216
    Other Liabilities, Total 42.436 48.45 15.707 7.661 1.033
    Total Equity 265.669 242.035 146.084 55.583 47.041
    Common Stock 0.013 0.013 0.013 0.01 0.009
    Additional Paid-In Capital 310.957 302.155 299.129 226.58 177.272
    Retained Earnings (Accumulated Deficit) -45.301 -60.133 -153.058 -171.007 -130.24
    Total Liabilities & Shareholders’ Equity 449.359 443.259 294.494 220.687 163.678
    Total Common Shares Outstanding 130.919 128.68 127.732 104.871 91.2614
    Preferred Stock - Non Redeemable, Net 0
    应收账款总额，净额 89.45 82.46 56.804 39.359 34.077
    Accounts Receivable - Trade, Net 89.45 82.46 56.804 39.359 34.077
    Total Inventory 24.783 25.022 27.799 22.918 13.321
    Other Current Assets, Total 0.812 0.599 0.412 0.196 0.114
    Property/Plant/Equipment, Total - Net 145.655 128.304 60.068 47.184 39.623
    Goodwill, Net 28.772 28.772 28.772 25.539 25.539
    Intangibles, Net 20.789 25.673 30.622 20.797 26.091
    Note Receivable - Long Term 0 0.556 0.477
    Accounts Payable 32.33 29.339 23.381 28.387 19.165
    Current Port. of LT Debt/Capital Leases 4.538 2.856 20.285 3.057 7.501
    Long Term Debt 66.231 70.769 53.044 83.118 39.062
    Capital Lease Obligations 0 11.442 14.431 10.154
    Property/Plant/Equipment, Total - Gross 208.453 186.033 129.589 112.996
    Accumulated Depreciation, Total -62.798 -57.729 -69.521 -65.812
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 216.822 222.609 230.526 231.543 217.851
    现金和短期投资 88.694 102.478 107.25 112.279 107.897
    Cash 88.694 102.478 107.25 112.279 107.897
    应收账款总额，净额 92.021 89.45 93.115 88.824 79.477
    Accounts Receivable - Trade, Net 92.021 89.45 93.115 88.824 79.477
    Total Inventory 25.539 24.783 24.683 23.235 22.737
    Prepaid Expenses 9.847 5.086 4.707 6.54 7.135
    Other Current Assets, Total 0.721 0.812 0.771 0.665 0.605
    Total Assets 446.107 449.359 457.272 456.357 436.272
    Property/Plant/Equipment, Total - Net 149.476 145.655 142.381 139.152 131.736
    Property/Plant/Equipment, Total - Gross 214.966 208.453 204.419 199.752 190.811
    Accumulated Depreciation, Total -65.49 -62.798 -62.038 -60.6 -59.075
    Goodwill, Net 28.772 28.772 28.772 28.772 28.772
    Intangibles, Net 19.56 20.789 22.01 23.231 24.452
    Other Long Term Assets, Total 31.477 31.534 33.583 33.659 33.461
    Total Current Liabilities 76.076 75.023 89.273 88.23 76.792
    Accounts Payable 30.31 32.33 37.952 36.373 27.935
    Accrued Expenses 40.757 38.155 46.317 48.261 44.194
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 5.009 4.538 5.004 3.596 3.227
    Other Current Liabilities, Total 0 0 0 1.436
    Total Liabilities 182.406 183.69 200.944 201.972 193.044
    Total Long Term Debt 64.86 66.231 67.6 68.969 69.869
    Long Term Debt 64.86 66.231 67.6 68.969 69.869
    Capital Lease Obligations
    Other Liabilities, Total 41.47 42.436 44.071 44.773 46.383
    Total Equity 263.701 265.669 256.328 254.385 243.228
    Common Stock 0.013 0.013 0.013 0.013 0.013
    Additional Paid-In Capital 312.573 310.957 309.102 307.374 303.261
    Retained Earnings (Accumulated Deficit) -48.885 -45.301 -52.787 -53.002 -60.046
    Total Liabilities & Shareholders’ Equity 446.107 449.359 457.272 456.357 436.272
    Total Common Shares Outstanding 131.226 130.919 130.915 130.885 128.887
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 15.532 94.902 17.234 -40.454 -64.831
    经营活动产生的现金 24.859 61.978 5.466 -33.528 -60.739
    营运资金的变化 -34.082 -37.71 -27.757 -9.667 -22.401
    投资活动产生的现金 -33.898 -31.22 -23.498 -6.234 -1.856
    其他投资现金流量项目，总计 0 -5.82 0 0.001
    融资活动产生的现金 -2.199 -1.036 42.468 78.727 81.642
    融资现金流项目 -1.256 -1.22 55.556 46.443 80.347
    股票的发行（报废），净额 2.07 2.198 2.823 0.897 0.119
    债务的发行（退还），净额 -3.013 -2.014 -15.911 31.387 1.176
    现金净变化 -11.238 29.722 24.436 38.965 19.047
    非现金物品 30.701 26.032 7.694 7.051 19.329
    经营活动产生的现金 5.845 5.781 4.438 3.388 3.309
    Amortization 4.883 4.949 3.745 6.043 3.669
    Deferred Taxes 1.98 -31.976 0.112 0.111 0.186
    资本支出 -33.898 -31.22 -17.678 -6.234 -1.857
    Cash Taxes Paid 1.201 0.607 0.061 0.049
    已付现金利息 2.649 5.787 9.609 8.148
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -2.969 15.532 8.046 7.831 0.087
    Cash From Operating Activities -5.077 24.859 17.059 11.606 1.411
    Cash From Operating Activities 2.694 5.845 4.331 2.875 1.347
    Amortization 1.23 4.883 3.662 2.442 1.221
    Non-Cash Items 5.795 30.701 23.822 12.698 5.654
    Cash Taxes Paid -0.128 1.201 -0.974 0.974 0.004
    Cash Interest Paid 1.271 2.649 1.787 1.041 0.627
    Changes in Working Capital -11.827 -34.082 -22.802 -14.24 -6.898
    Cash From Investing Activities -7.562 -33.898 -23.242 -12.84 -6.672
    Capital Expenditures -7.562 -33.898 -23.242 -12.84 -6.672
    Cash From Financing Activities -1.236 -2.199 -0.324 -0.35 -0.765
    Financing Cash Flow Items -0.298 -1.256 -1.256 -1.254 -0.488
    Issuance (Retirement) of Stock, Net 0 2.07 2.07 2.042 0.291
    Issuance (Retirement) of Debt, Net -0.938 -3.013 -1.138 -1.138 -0.568
    Net Change in Cash -13.875 -11.238 -6.507 -1.584 -6.026
    Other Investing Cash Flow Items, Total
    Deferred Taxes 1.98
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Ades (Alan A) Individual Investor 11.6136 15244272 0 2023-04-10 LOW
    Nussdorf (Glenn H) Individual Investor 11.3999 14963663 0 2023-04-10 LOW
    Erani (Dennis) Individual Investor 7.6517 10043701 -9106 2021-12-28
    Soleus Capital Management, L.P. Hedge Fund 7.5064 9853063 2490000 2023-03-31 HIGH
    Organo PFG LLC Corporation 6.3076 8279490 0 2023-04-10 LOW
    RED Holdings, L.L.C. Corporation 5.6317 7392328 7392328 2021-12-28
    BlackRock Institutional Trust Company, N.A. Investment Advisor 2.9574 3882001 -6530489 2023-03-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.8257 3709093 -1105755 2023-03-31 LOW
    Organo Investors, L.L.C. Corporation 2.1727 2851984 0 2023-04-10 LOW
    AQR Capital Management, LLC Investment Advisor/Hedge Fund 1.9444 2552213 361648 2023-03-31 MED
    Citadel Advisors LLC Hedge Fund 1.9441 2551890 1876307 2023-03-31 HIGH
    Two Sigma Investments, LP Hedge Fund 1.607 2109408 468570 2023-03-31 HIGH
    Federated Hermes MDTA LLC Investment Advisor/Hedge Fund 1.4436 1894916 -998694 2023-03-31 MED
    Millennium Management LLC Hedge Fund 1.207 1584274 -142988 2023-03-31 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.1525 1512735 46040 2023-03-31 LOW
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 1.0732 1408713 219098 2023-03-31 MED
    Assenagon Asset Management S.A. Investment Advisor 1.0401 1365197 -74843 2023-03-31 HIGH
    D. E. Shaw & Co., L.P. Hedge Fund 1.0215 1340843 909003 2023-03-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.9731 1277300 -1207063 2023-03-31 LOW
    Renaissance Technologies LLC Hedge Fund 0.9511 1248400 75002 2023-03-31 HIGH

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    535K+

    交易者

    87K+

    每月活跃客户

    $113M+

    每月投资额

    $64M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    Organogenesis Holdings Inc. Company profile

    关于 Organogenesis Holdings Inc.

    Organogenesis Holdings Inc.是一家再生医学公司,专注于伤口护理和外科及运动医学市场解决方案的开发、生产和商业化。 它的解决方案解决了糖尿病、肥胖症、心血管和外周血管疾病以及吸烟等合并症。 伤口护理产品包括用于治疗静脉性腿部溃疡（VLUs）和糖尿病足溃疡（DFUs）的Apligraf；用于治疗糖尿病足溃疡（DFU）的Dermagraft；作为抗菌屏障的PuraPly AM和PuraPly XT用于各种类型的伤口；以及用于解决各种伤口大小和类型的Affinity和NuShield伤口覆盖物。 其外科和运动医学产品包括用于膝关节骨关节炎治疗的ReNu；用于腰椎骨融合的NuCel；用于定向软组织修复手术的NuShield和Affinity屏障产品；以及用于外科手术中开放伤口管理的PuraPly AM。

    Industry: Biotechnology & Medical Research (NEC)

    85 Dan Rd
    CANTON
    MASSACHUSETTS 02021-2810
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    Oil - Crude

    73.25 Price
    +1.030% 1D Chg, %
    多头隔夜费 -0.0156%
    空头隔夜费 -0.0063%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    Gold

    1,946.86 Price
    +0.340% 1D Chg, %
    多头隔夜费 -0.0090%
    空头隔夜费 0.0008%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    US100

    14,280.30 Price
    +0.050% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 1.8

    BTC/USD

    26,458.70 Price
    +0.300% 1D Chg, %
    多头隔夜费 -0.0616%
    空头隔夜费 0.0137%
    隔夜费时间 21:00 (UTC)
    价差 60.00

    还在找一位您可以信任的经纪商吗？

    加入成为全球535,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易